The Rosuvastatin In TrAnsplant Recipients Study

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Disorder Related to Renal TransplantationHypercholesterolemia
Interventions
DRUG

Rosuvastatin

20 mg rosuvastatin for 4 weeks

Trial Locations (1)

0027

Oslo University Hospital, Rikshospitalet, Oslo

All Listed Sponsors
collaborator

Oslo University Hospital

OTHER

lead

University of Oslo School of Pharmacy

OTHER

NCT01524601 - The Rosuvastatin In TrAnsplant Recipients Study | Biotech Hunter | Biotech Hunter